Marcelo Bonini
Senior Member & Chair
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Histones scaffold genomic DNA and regulate access to the transcriptional machinery. However, naturally occurring histone variants can alter histone-DNA interactions, DNA and histone modifications, and the chromatin interactome. Hence, alterations in histone variant deposition can disrupt chromatin, and are increasingly recognized as a way to trigger various disease, including cancer. While significant attention has been placed on the biochemical and functional roles of H2A, H3, and H4 histone variants, the variants of H2B remain largely understudied. Here, we show that H2B variants are dysregulated in breast cancer and that certain variants are associated with specific breast cancer subtypes. HIST1H2BO overexpression (in particular) is more common in Asian, African American/Black, and young female populations and is associated with a worse prognosis. In vitro studies show that H2B1O compacts nucleosome structure. Incorporating H2B1O into chromatin activates pro-inflammatory and oncogenic pathways, induces epithelial-to-mesenchymal transition (EMT), and generates resistance to first-line chemotherapeutic agents. Thus, H2B1O acts much like an onco-histone, with H2B variant expression being a prognostic biomarker for breast cancer and a potential new target for drug therapies to enhance treatment efficacy.
Year:
2026
Lipid metabolism and the serine, one-carbon, glycine (SOG) and methionine pathways are independently and significantly correlated with estrogen receptor–negative breast cancer (ERneg BC). Here, we propose a link between lipid metabolism and ERneg BC through phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the de novo serine pathway. We demonstrate that the metabolism of the paradigmatic medium-chain fatty acid octanoic acid leads to a metabolic shift toward the SOG and methionine pathways. PHGDH plays a role in both the forward direction, contributing to the production of S-adenosylmethionine, and the reverse direction, generating the oncometabolite 2-hydroxyglutarate, leading to epigenomic reprogramming and phenotypic plasticity. The methionine cycle is closely linked to the transsulfuration pathway. Consequently, we observe that the shift increases the antioxidant glutathione, which mitigates reactive oxygen species (ROS), enabling survival of a subset of cells that have undergone DNA damage. These metabolic changes contribute to several hallmarks of cancer.
Year:
2025
Collaborators (12)
Peng Gao
Northwestern University Feinberg School of Medicine
Yuan Luo
Chief AI Officer and Associate Professor
Northwestern University
Maxim Frolov
University of Chicago
Curtis W. McCloskey
Assistant Professor
UPMC Hillman Cancer Center
Daniël Melters
Staff Scientist
National Institutes of Health
Rama Khokha
Professor
University of Toronto
Elizaveta V Benevolenskaya
Professor
University of Illinois Chicago (UIC)
Xiaoling Xuei
Research professor
Indiana University School of Medicine
Jonathan D Licht
Van Andel Institute
Seema Khan
Professor
Northwestern University Feinberg School of Medicine
Yvonne Fondufe-Mittendorf
Professor
Van Andel Institute
Maria Paula Zappia
Research Assistant Professor
University of Chicago
Make your next move.
Prepare your application
Review drafts before you send them.